×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Applied Molecular Transport Inc. (AMTI) NASDAQ

$0.26 - (-)

Market Cap: -

As of 12/26/23 12:00 AM EST. Market closed.

(AMTI)

Applied Molecular Transport Inc. (AMTI)
NASDAQ

$0.26
- (-)

Market Cap: -

As of 12/26/23 12:00 AM EST. Market closed.

Add to Portfolio

applied molecular transport is developing a pipeline of transformative, targeted oral biological therapeutics that promise to redefine the future of biopharmaceuticals. our deep scientific foundations in mucosal immunology and microbiome-epithelial interfaces have led to the development of powerful technology platforms that are fueling a unique pipeline of first-in-class molecules to treat a wide ... read more

applied molecular transport is developing a pipeline of transformative, targeted oral biological therapeutics that promise to redefine the future of biopharmaceuticals. our deep scientific foundations in mucosal immunology and microbiome-epithelial interfaces have led to the development of powerful technology platforms that are fueling a unique pipeline of first-in-class molecules to treat a wide range of grievous diseases. our oral biopharmaceutical products mimic the biology of microbial and other natural processes that modulate health and disease via mucosal immunology pathways. our targeted therapeutics are directed to the right location to intercept disease at the point of origin of dysregulation. we are advancing a pipeline of targeted oral biological therapeutics to treat autoimmune, inflammation and other diseases, including those associated with cancer, metabolic and hepatologic disorders. our overriding patient-centric goal is to open new biological possibilities based on nov read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
.
PRICE CHART FOR APPLIED MOLECULAR TRANSPORT INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.26
Days Range
$0.26 - $0.31
52 week range
- - -
Volume
240,468
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
41,336,563
Open
-
Previous Close
$0.26
Days Range
$0.26 - $0.31
52 week range
- - -
Volume
240,468
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
41,336,563
FINANCIAL STATEMENTS FOR APPLIED MOLECULAR TRANSPORT INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APPLIED MOLECULAR TRANSPORT INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Mahmood Tahir Ph.D.DirectorNov 22, 2023 Sale$0.16286,32046,785484,738Nov 27, 2023, 04:52 PM
Hants BrandonCFONov 22, 2023 Sale$0.1661,49410,054301,225Nov 27, 2023, 04:47 PM
Cross ShawnCEO & Chair of the BoardNov 22, 2023 Sale$0.16110,80218,116545,499Nov 24, 2023, 04:21 PM
Hants BrandonCFONov 15, 2023 Sale$0.1650,1468,053362,719Nov 16, 2023, 05:38 PM
Cross ShawnCEO & Chair of the BoardNov 15, 2023 Sale$0.1690,44714,526656,301Nov 16, 2023, 05:36 PM
Mahmood Tahir Ph.D.DirectorOct 06, 2023 Sale$0.16184,44230,378771,058Oct 10, 2023, 05:02 PM
Mahmood Tahir Ph.D.DirectorJun 02, 2023 Sale$0.241,99248171,634Oct 04, 2023, 07:30 PM
Mahmood Tahir Ph.D.DirectorSep 05, 2023 Sale$0.212,24546669,389Oct 04, 2023, 07:30 PM
Hants BrandonCFOSep 05, 2023 Sale$0.21718149412,865Oct 04, 2023, 07:28 PM
Hants BrandonCFOJun 02, 2023 Sale$0.242,203531414,143Oct 04, 2023, 07:28 PM
Cross ShawnCEO & Chair of the BoardSep 05, 2023 Sale$0.211,253260746,748Oct 04, 2023, 07:27 PM
Cross ShawnCEO & Chair of the BoardJun 02, 2023 Sale$0.244,3061,038749,014Oct 04, 2023, 07:27 PM
Hants BrandonCFOSep 29, 2023 Sale$0.16107,54017,045415,786Oct 02, 2023, 07:10 PM
Cross ShawnCEO & Chair of the BoardSep 29, 2023 Sale$0.16193,96030,743752,307Oct 02, 2023, 07:02 PM
Rich Douglas A.Chief Technical OfficerMar 01, 2023 Sale$0.5048224149,316Mar 03, 2023, 05:46 PM
Mahmood Tahir Ph.D.Chief Executive OfficerMar 01, 2023 Sale$0.501,80290173,626Mar 03, 2023, 05:44 PM
Kanwar BittooChief Medical OfficerMar 01, 2023 Sale$0.5053927078,005Mar 03, 2023, 05:42 PM
Hants BrandonCFOMar 01, 2023 Sale$0.5050425232,315Mar 03, 2023, 05:22 PM
Cross ShawnPresident & COOMar 01, 2023 Sale$0.5093446760,156Mar 03, 2023, 05:20 PM
Rich Douglas A.Chief Technical OfficerDec 02, 2022 Sale$1.054,2294,44149,798Dec 06, 2022, 05:03 PM
Mrsny Randall Ph.D.DirectorDec 02, 2022 Sale$1.0541843921,136Dec 06, 2022, 05:02 PM
Kanwar BittooChief Medical OfficerDec 02, 2022 Sale$1.053,4883,66378,544Dec 06, 2022, 04:59 PM
Hants BrandonCFODec 02, 2022 Sale$1.051,9592,05732,819Dec 06, 2022, 04:58 PM
Cross ShawnPresident & COODec 02, 2022 Sale$1.053,8934,08861,090Dec 06, 2022, 04:56 PM
VanDevender AaronDirectorNov 28, 2022 Buy$1.0050,00049,975212,659Nov 29, 2022, 05:27 PM
VanDevender AaronDirectorNov 25, 2022 Buy$1.00100,00099,660162,659Nov 29, 2022, 05:27 PM
Rich Douglas A.Chief Technical OfficerSep 01, 2022 Sale$1.4244863654,027Sep 06, 2022, 07:25 PM
Mrsny Randall Ph.D.DirectorSep 01, 2022 Sale$1.4240457421,554Sep 06, 2022, 07:23 PM
Mahmood Tahir Ph.D.Chief Executive OfficerSep 01, 2022 Sale$1.421,7232,44774,154Sep 06, 2022, 07:22 PM
Kanwar BittooChief Medical OfficerSep 01, 2022 Sale$1.4250371482,028Sep 06, 2022, 07:20 PM
Hants BrandonCFOSep 01, 2022 Sale$1.4246265634,774Sep 06, 2022, 07:18 PM
Cross ShawnPresident & COOSep 01, 2022 Sale$1.428841,25565,399Sep 06, 2022, 07:17 PM
Rich Douglas A.Chief Technical OfficerJun 02, 2022 Sale$3.042,6027,91754,475Jun 03, 2022, 07:29 PM
Rich Douglas A.Chief Technical OfficerJun 01, 2022 Sale$2.972,1236,30157,077Jun 03, 2022, 07:29 PM
Mrsny Randall Ph.D.DirectorJun 02, 2022 Sale$3.043921,19320,039Jun 03, 2022, 07:26 PM
Mrsny Randall Ph.D.DirectorJun 01, 2022 Sale$2.9731994720,431Jun 03, 2022, 07:26 PM
Mahmood Tahir Ph.D.Chief Executive OfficerJun 02, 2022 Sale$3.041,6935,15174,925Jun 03, 2022, 07:24 PM
Mahmood Tahir Ph.D.Chief Executive OfficerJun 01, 2022 Sale$2.971,3824,10276,618Jun 03, 2022, 07:24 PM
Kanwar BittooChief Medical OfficerJun 02, 2022 Sale$3.042,1966,68180,612Jun 03, 2022, 07:22 PM
Kanwar BittooChief Medical OfficerJun 01, 2022 Sale$2.971,7925,31882,808Jun 03, 2022, 07:22 PM
Hants BrandonCFOJun 02, 2022 Sale$3.041,1223,41433,263Jun 03, 2022, 07:21 PM
Hants BrandonCFOJun 01, 2022 Sale$2.979152,71634,385Jun 03, 2022, 07:21 PM
Cross ShawnPresident & COOJun 02, 2022 Sale$3.042,1666,59065,867Jun 03, 2022, 07:20 PM
Cross ShawnPresident & COOJun 01, 2022 Sale$2.971,7675,24467,983Jun 03, 2022, 07:20 PM
Lamond DavidDirectorMay 23, 2022 Buy$3.2633,500109,2101,077,519May 23, 2022, 06:18 PM
Lamond DavidDirectorMay 20, 2022 Buy$3.0833,000101,6401,044,019May 23, 2022, 06:18 PM
EPIQ Capital Group, LLCManaging Member of 10% OwnerMay 12, 2022 Buy$3.8832,380125,6348,307,755May 16, 2022, 05:49 PM
EPIQ Capital Group, LLCManaging Member of 10% OwnerMay 13, 2022 Buy$4.1729,763124,1248,337,518May 16, 2022, 05:49 PM
VanDevender AaronDirectorMar 01, 2022 Buy$6.3445,888290,93062,659Mar 02, 2022, 05:15 PM
VanDevender AaronDirectorFeb 28, 2022 Buy$6.514,11226,76916,771Mar 02, 2022, 05:15 PM
Mahmood Tahir Ph.D.Chief Executive OfficerJan 28, 2022 Buy$7.883,00023,6403,000Jan 31, 2022, 05:40 PM
Kanwar BittooChief Medical OfficerDec 22, 2021 Option Exercise$2.3831,50074,97031,500Dec 23, 2021, 05:50 PM
Mrsny Randall Ph.D.Chief Scientific OfficerDec 09, 2021 Buy$14.993,50052,4643,500Dec 10, 2021, 04:28 PM
EPIQ Capital Group, LLCManaging member of 10% ownerNov 17, 2021 Buy$22.387,135159,6848,275,375Nov 18, 2021, 03:41 PM
EPIQ Capital Group, LLCManaging member of 10% ownerNov 16, 2021 Buy$22.574,00090,2988,268,240Nov 18, 2021, 03:41 PM
Kim Helen SusanDirectorAug 27, 2021 Sale$30.9495129,425575,250Aug 27, 2021, 08:45 PM
Kim Helen SusanDirectorAug 26, 2021 Sale$30.1614,063424,074576,509Aug 27, 2021, 08:45 PM
Kim Helen SusanDirectorAug 25, 2021 Sale$30.089,478285,075590,014Aug 25, 2021, 09:07 PM
Kim Helen SusanDirectorAug 24, 2021 Sale$30.0350815,255599,495Aug 25, 2021, 09:07 PM
Cross ShawnChief Financial OfficerAug 23, 2021 Option Exercise$4.619,70044,7179,700Aug 23, 2021, 07:40 PM
Cross ShawnChief Financial OfficerAug 19, 2021 Option Exercise$4.613001,383300Aug 23, 2021, 07:40 PM
Cross ShawnChief Financial OfficerAug 23, 2021 Sale$30.129,700292,1900Aug 23, 2021, 07:40 PM
Cross ShawnChief Financial OfficerAug 19, 2021 Sale$30.013009,0030Aug 23, 2021, 07:40 PM
Bhatt ElizabethChief Bus. & Strategy OfficerJul 21, 2021 Option Exercise$4.619,00041,4909,000Jul 22, 2021, 07:59 PM
Bhatt ElizabethChief Bus. & Strategy OfficerJul 21, 2021 Sale$36.689,000330,0972,360Jul 22, 2021, 07:59 PM
Kanwar BittooChief Medical OfficerJul 07, 2021 Option Exercise$2.387,50017,8507,500Jul 08, 2021, 07:49 PM
Kanwar BittooChief Medical OfficerJul 07, 2021 Sale$42.097,500315,693849Jul 08, 2021, 07:49 PM
Kim Helen SusanDirectorJul 02, 2021 Sale$43.32200,0008,663,730601,241Jul 06, 2021, 07:22 PM
Bhatt ElizabethChief Bus. & Strategy OfficerApr 21, 2021 Option Exercise$4.619,00041,4909,000Apr 22, 2021, 06:29 PM
Bhatt ElizabethChief Bus. & Strategy OfficerApr 21, 2021 Sale$40.519,000364,5578,029Apr 22, 2021, 06:29 PM
Kanwar BittooChief Medical OfficerApr 07, 2021 Option Exercise$2.387,50017,8507,500Apr 08, 2021, 09:15 PM
Kanwar BittooChief Medical OfficerApr 07, 2021 Sale$54.797,500410,9465,249Apr 08, 2021, 09:15 PM
Kim Helen SusanDirectorJul 02, 2020 Option Exercise$0.02800,00016,000800,000Jul 06, 2020, 05:41 PM
Lamond DavidDirectorJun 09, 2020 Option Exercise$14.0071,4301,000,020986,019Jun 11, 2020, 06:38 PM
EPIQ Capital Group, LLCManaging Member of 10% ownerJun 09, 2020 Buy$14.002,720,00038,080,0008,264,240Jun 11, 2020, 05:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Mahmood Tahir Ph.D.Director11/22/202346,785
Hants BrandonCFO11/22/202310,054
Cross ShawnCEO & Chair of the Board11/22/202318,116
Hants BrandonCFO11/15/20238,053
Cross ShawnCEO & Chair of the Board11/15/202314,526
Mahmood Tahir Ph.D.Director10/06/202330,378
Mahmood Tahir Ph.D.Director06/02/2023481
Mahmood Tahir Ph.D.Director09/05/2023466
Hants BrandonCFO09/05/2023149
Hants BrandonCFO06/02/2023531
Cross ShawnCEO & Chair of the Board09/05/2023260
Cross ShawnCEO & Chair of the Board06/02/20231,038
Hants BrandonCFO09/29/202317,045
Cross ShawnCEO & Chair of the Board09/29/202330,743
Rich Douglas A.Chief Technical Officer03/01/2023241
Mahmood Tahir Ph.D.Chief Executive Officer03/01/2023901
Kanwar BittooChief Medical Officer03/01/2023270
Hants BrandonCFO03/01/2023252
Cross ShawnPresident & COO03/01/2023467
Rich Douglas A.Chief Technical Officer12/02/20224,441
Mrsny Randall Ph.D.Director12/02/2022439
Kanwar BittooChief Medical Officer12/02/20223,663
Hants BrandonCFO12/02/20222,057
Cross ShawnPresident & COO12/02/20224,088
VanDevender AaronDirector11/28/202249,975
VanDevender AaronDirector11/25/202299,660
Rich Douglas A.Chief Technical Officer09/01/2022636
Mrsny Randall Ph.D.Director09/01/2022574
Mahmood Tahir Ph.D.Chief Executive Officer09/01/20222,447
Kanwar BittooChief Medical Officer09/01/2022714
Hants BrandonCFO09/01/2022656
Cross ShawnPresident & COO09/01/20221,255
Rich Douglas A.Chief Technical Officer06/02/20227,917
Rich Douglas A.Chief Technical Officer06/01/20226,301
Mrsny Randall Ph.D.Director06/02/20221,193
Mrsny Randall Ph.D.Director06/01/2022947
Mahmood Tahir Ph.D.Chief Executive Officer06/02/20225,151
Mahmood Tahir Ph.D.Chief Executive Officer06/01/20224,102
Kanwar BittooChief Medical Officer06/02/20226,681
Kanwar BittooChief Medical Officer06/01/20225,318
Hants BrandonCFO06/02/20223,414
Hants BrandonCFO06/01/20222,716
Cross ShawnPresident & COO06/02/20226,590
Cross ShawnPresident & COO06/01/20225,244
Lamond DavidDirector05/23/2022109,210
Lamond DavidDirector05/20/2022101,640
EPIQ Capital Group, LLCManaging Member of 10% Owner05/12/2022125,634
EPIQ Capital Group, LLCManaging Member of 10% Owner05/13/2022124,124
VanDevender AaronDirector03/01/2022290,930
VanDevender AaronDirector02/28/202226,769
Mahmood Tahir Ph.D.Chief Executive Officer01/28/202223,640
Kanwar BittooChief Medical Officer12/22/202174,970
Mrsny Randall Ph.D.Chief Scientific Officer12/09/202152,464
EPIQ Capital Group, LLCManaging member of 10% owner11/17/2021159,684
EPIQ Capital Group, LLCManaging member of 10% owner11/16/202190,298
Kim Helen SusanDirector08/27/202129,425
Kim Helen SusanDirector08/26/2021424,074
Kim Helen SusanDirector08/25/2021285,075
Kim Helen SusanDirector08/24/202115,255
Cross ShawnChief Financial Officer08/23/202144,717
Cross ShawnChief Financial Officer08/19/20211,383
Cross ShawnChief Financial Officer08/23/2021292,190
Cross ShawnChief Financial Officer08/19/20219,003
Bhatt ElizabethChief Bus. & Strategy Officer07/21/202141,490
Bhatt ElizabethChief Bus. & Strategy Officer07/21/2021330,097
Kanwar BittooChief Medical Officer07/07/202117,850
Kanwar BittooChief Medical Officer07/07/2021315,693
Kim Helen SusanDirector07/02/20218,663,730
Bhatt ElizabethChief Bus. & Strategy Officer04/21/202141,490
Bhatt ElizabethChief Bus. & Strategy Officer04/21/2021364,557
Kanwar BittooChief Medical Officer04/07/202117,850
Kanwar BittooChief Medical Officer04/07/2021410,946
Kim Helen SusanDirector07/02/202016,000
Lamond DavidDirector06/09/20201,000,020
EPIQ Capital Group, LLCManaging Member of 10% owner06/09/202038,080,000
Load More Insider Transactions
FUNDS WITH A POSITION IN APPLIED MOLECULAR TRANSPORT INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.456,4090%ExitedOther
RENAISSANCE TECHNOLOGIES LLC282,1870.00008%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC139,8080%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR APPLIED MOLECULAR TRANSPORT INC
STOCK BUYBACKS FOR APPLIED MOLECULAR TRANSPORT INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
1.06%
1Q
09/30/2023
03/31/2023
1.44%
2Q
09/30/2023
12/31/2022
1.82%
3Q
09/30/2023
09/30/2022
2.15%
4Q
09/30/2023
06/30/2022
2.59%
5Q
09/30/2023
03/31/2022
2.87%
6Q
09/30/2023
12/31/2021
3.12%
7Q
09/30/2023
09/30/2021
3.42%
8Q
09/30/2023
06/30/2021
4.26%
9Q
09/30/2023
03/31/2021
12.87%
10Q
09/30/2023
12/31/2020
73.75%
11Q
09/30/2023
09/30/2020
14.33%
12Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
1.06%
1Q
03/31/2023
1.44%
2Q
12/31/2022
1.82%
3Q
09/30/2022
2.15%
4Q
06/30/2022
2.59%
5Q
03/31/2022
2.87%
6Q
12/31/2021
3.12%
7Q
09/30/2021
3.42%
8Q
06/30/2021
4.26%
9Q
03/31/2021
12.87%
10Q
12/31/2020
73.75%
11Q
09/30/2020
14.33%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR APPLIED MOLECULAR TRANSPORT INC
LOADING...